Journal
THERANOSTICS
Volume 4, Issue 11, Pages 1085-1095Publisher
IVYSPRING INT PUBL
DOI: 10.7150/thno.9933
Keywords
Nanomedicine; Endocytosis; Autophagy; Docetaxel; Chloroquine; Dendrimers
Categories
Funding
- National Natural Science Foundation of China [31270019, 51203085, 81302553]
- Program for New Century Excellent Talents in University [NCET-11-0275]
- Natural Science Foundation of Guangdong Province [S2012010010046, S2012040006820]
- Science, Technology & Innovation Commission of Shenzhen Municipality [JCYJ20120616213729920, JCYJ20120614191936420, KQC201105310021A, JC201005270308A]
Ask authors/readers for more resources
Dendrimers are synthetic nanocarriers that comprise a highly branched spherical polymer as new, efficient tools for drug delivery. However, the fate of nanocarriers after being internalized into cells has seldom been studied. Docetaxel loaded dendritic copolymer H40-poly(D, L-lactide) nanoparticles, referred to as DTX-H40-PLA NPs, were prepared and used as a model to evaluate whether the NPs were sequestered by autophagy and fused with lysosomes. Besides being degraded through the endolysosomal pathway, the DTX-loaded H40-PLA NPs were also sequestered by autophagosomes and degraded through the autolysosomal pathway. DTX-loaded H40-PLA NPs may stop exerting beneficial effects after inducing autophagy of human MCF-7 cancer cells. Co-delivery of autophagy inhibitor such as chloroquine and chemotherapeutic drug DTX by dendritic copolymer NPs greatly enhanced cancer cell killing in vitro, and decreased both the volume and weight of the tumors in severe combined immunodeficient mice. These findings provide valuable evidence for development of nanomedicine such as dendritic copolymer NPs for clinical application.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available